Global Virus Testing Kits Market, By Test Type (Agglutination Assays, Solid-Phase Assays, Polymerase Chain Reaction (PCR)-Based Tests, DFA, Others), By Virus Type (Influenza, Hepatitis, HIV, Measles, Smallpox, Coronavirus, Dengue, Ebola, SARS, , Rota Virus MERS, Others), By Genetic Information (DNA, RNA), By Distribution Channel (Direct Selling, Medical Store, Online, Others), By End User (Diagnostic & Clinical Laboratories, Academic & Research Institutes, Contract Research Organizations, And Others), Global Opportunity Analysis and Industry Forecast, 2020-2027
Global Virus Testing Kits Market Definition:
Virus test kits are diagnostic tools kits which help to detect the antibodies of infected people by using some testing methods, such as DFA, agglutinating testing, PCR, and solid-stage testing. Viruses progressively damage lymphocytes which are an important part of the body’s immune defence. The technology platform such as enzyme-assisted nanocomplexes for visual identification of nucleic acids can be designed to detect a wide range of diseases. Also, it helps to control emerging infectious diseases and high-prevalence infections. These kits are based on techniques that are also used to detect virus antibodies in a virology laboratory that performs various tests, such as rapid antigen testing, serology or molecular diagnostics. Global Virus Testing Kits Market Analysis:
Virus Testing Kits Market is expected to register a lucrative CAGR in the forecast period of 2020-2027. The report contains data from the base year 2019 and historic 2018. Rising rapid and point-of-care testing, increasing prevalence of virus-based diseases and early diagnosis rate are the major factors for the market growth. Companies continuously invest in research and development activities for novel viral testing kits. Moreover, the COVID-19 pandemic also boost the market exponentially in the upcoming few years. These factors contribute to the development of virus test kits worldwide and boost the market. However, high costs and lack of awareness may hinder the market growth.
Global Virus Testing Kits Dynamics:
Market Drivers
• Rising cases of covid 19
• Introduction of novel viral testing kits
• Rising awareness and improving diagnosis-seeking rate
• Growing adoption of rapid and point-of-care testing
Market Restraints
• Stringent and regulation
• High cost of kits
• Lack of reimbursement.
Global Virus Testing Kits Market Segmentation:
By Test Type
• DFA
• Polymerase Chain Reaction (PCR)-Based Tests
• Agglutination Assays
• Solid-Phase Assays
• Others
By Virus Type
• Coronavirus
• Influenza
• Hepatitis
• HIV
• Measles
• Smallpox
• Dengue
• Ebola
• Rota Virus
• SARS
• MERS
• Others
By Genetic Information
• DNA
• RNA
By Distribution Channel
• Direct Selling
• Medical Store
• Online
• Others
By End User
• Diagnostic & Clinical Laboratories
• Academic & Research Institutes
• Contract Research Organizations
• Others
By Geography
• North America
o U.S.
o Canada
• Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Russia
o Poland
o Turkey
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o ASEAN
o Rest of Asia-Pacific
• Latin America
o Mexico
o Brazil
o Argentina
o Rest of Latin America
• Middle East and Africa
o GCC Countries
o South Africa
o North Africa
o Egypt
o Israel
o Rest of Middle East and Africa
Recent Developments
• In 2020, Abbott, Launched the COVID-19 test product “Abbott’s architect i1000SR and i2000SR” laboratory instruments. this product launch helped the company boost their revenue growth
• Competitive Analysis:
The Global Virus Testing Kits Market is highly competitive, and major players have used various approaches to raise their footprints in this market such as new product advancements, acquisitions, contracts, joint ventures, alliances, acquisitions and others. The scope of the study includes Virus Testing Kits Market revenue for Global, Europe, North America, Asia-Pacific, South America and the Middle East & Africa.
Key Market Players:
Key players operating in the Virus Testing Kits are:-
• AUTOBIO DIAGNOSTICS CO., LTD.
• ABBOTT LABORATORIES
• BIOMERIEUX SA
• BIO-RAD LABORATORIES INC.
• BUNDI INTERNATIONAL DIAGNOSTICS LTD.
• F. HOFFMAN LA ROCHE, LTD.
• LUMINEX CORPORATION
• MERCK & CO., INC.
• CERTEST BIOTEC
• MYLAN NV
• NECTAR LIFESCIENCES LTD.
• PERKINELMER INC.
• HOLOGIC INC.
• QIAGEN NV S.L.
• CORISBIOCONCEPT SPRL
• QUIDEL CORPORATION
• BECKMAN COULTER, INC.
• THERMO FISHER SCIENTIFIC INC
• SIEMENS HEALTHINEERS AG
• BECTON, DICKINSON AND COMPANY
Research Methodology: Global Virus Testing Kits Market
Data collection modules with large sample sizes are used for data collection and base year analysis. Market share analysis and key trend analysis are the major factors for success in any market report. Market statistical and coherent models are used to analyze the market data. Please request an analyst call for more information on the research methodology
Phoenix research consultants use their proprietary research methodology to evaluate data that involves data mining, analysis of the impact of data variables on the market, and primary validation. Furthermore, other data models consist of a market overview and guide, company matrix, key intensity vendor mapping, market forecasting analysis, company share analysis, top-down and bottom-up analysis and others.
Demand and Supply Side – Primary Research Respondent
Demand Side: Medical diagnostic equipment Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Players, Healthcare Authorities, Academics and Universities, Technological Expertise, researchers, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, Senior and mid-level Executives, Distributors, Market Intelligence, and Regulatory Authority Managers among others.
Report Insights:
• To gain insights into the competitive milieu in the market
• End-user assessment /Customer behaviours
• Detailed Demand and Supply Assessment
• Key market drivers and restraints Analysis
• Competitive landscape of the key players involved
• In-depth analysis of the market segmentation
1. Introduction
1.1. Objectives Of The Study
1.2. Market Scope
1.2.1. Market Covered
1.2.2. Years Considered For The Study
1.3. Market Definition
1.4. Currency
1.5. Limitations
1.6. Stakeholders
2. Research Methodology
2.1. Research Design
2.1.1. Research Methodology Snapshot
2.1.2. Secondary Data
2.1.3. Key Data From Secondary Sources
2.1.4. Primary Data
2.1.5. Key Data From Primary Sources
2.2. Market Size Estimation
2.3. Market Breakdown And Data Triangulationmarket
2.4. Market Share Estimation
2.5. Assumptions For The Study
3. Executive Summary
4. Epidemiology
5. Industry Insights
5.1. Value Chain
5.2. Regulatory Landscape
5.2.1. North America
5.2.2. Europe
5.2.3. Asia
5.2.4. Row
5.3. Key Pipeline Products
5.4. Public-private Initiatives
5.5. Funding
6. Market Dynamics
6.1. Introduction
6.2. Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Opportunities
6.2.4. Challenges
7. Global Virus Testing Kits Market, By Test Type
7.1. Introduction
7.2. Dfa
7.3. Polymerase Chain Reaction (Pcr)-based Tests
7.4. Agglutination Assays
7.5. Solid-phase Assays
7.6. Others
8. Global Virus Testing Kits Market, By Virus Type
8.1. Introduction
8.2. Coronavirus
8.3. Influenza
8.4. Hepatitis
8.5. Hiv
8.6. Measles
8.7. Smallpox
8.8. Dengue
8.9. Ebola
8.10. Rota Virus
8.11. Sars
8.12. Mers
8.13. Others
9. Global Virus Testing Kits Market, By Genetic Information
9.1. Introduction
9.2. Dna
9.3. Rna
10. Global Virus Testing Kits Market, By Distribution Channel
10.1. Introduction
10.2. Direct Selling
10.3. Medical Store
10.4. Online
11. Other Global Virus Testing Kits Market, By End User
11.1. Introduction
11.2. Diagnostic & Clinical Laboratories
11.3. Academic & Research Institutes
11.4. Contract Research Organizations
11.5. Others
12. Global Virus Testing Kits Market, By Region
12.1. Introduction
12.2. North America
12.2.1. U.s.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. Italy
12.3.3. U.k.
12.3.4. France
12.3.5. Spain
12.3.6. Netherlands
12.3.7. Belgium
12.3.8. Switzerland
12.3.9. Russia
12.3.10. Poland
12.3.11. Turkey
12.3.12. Rest Of Europe
12.4. Asia-pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. South Korea
12.4.5. Australia
12.4.6. Asean
12.4.7 Rest Of Asia-pacific
13.1. Latin America
13.1.1. Mexico
13.1.2. Brazil
13.1.3. Argentina
13.14. Rest Of Latin America
14.1. Middle East And Africa
14.1.1. Gcc Countries
14.1.2. South Africa
14.1.3. North Africa
14.1.4. Egypt
14.1.5. Israel
14.1.6. Rest Of Middle East And Africa
15. Competitive Landscape
15.1. Competitive Landscape And Trends.
15.2. Agreements, Partnerships, And Collaborations
15.3. Product Launches And Approvals
15.4. Acquisitions
15.5. Expansions
16. Company Profile
16.1. Abbott Laboratories
16.1.1. Overview
16.1.2. Revenue Analysis
16.1.3. Product Portfolio
16.1.4. Recent Development
16.2. Autobio Diagnostics Co., Ltd
16.2.1. Overview
16.2.2. Revenue Analysis
16.2.3. Product Portfolio
16.2.4. Recent Development
16.3. Beckman Coulter, Inc
16.3.1. Overview
16.3.2. Revenue Analysis
16.3.3. Product Portfolio
16.3.4. Recent Development
16.4. Becton
16.4.1. Overview
16.4.2. Revenue Analysis
16.4.3. Product Portfolio
16.4.4. Recent Development
16.5. Dickinson And Company
16.5.1. Overview
16.5.2. Revenue Analysis
16.5.3. Product Portfolio
16.5.4. Recent Development
16.6. Biomerieux Sa
16.6.1. Overview
16.6.2. Revenue Analysis
16.6.3. Product Portfolio
16.6.4. Recent Development
16.7. Bio-rad Laboratories
16.7.1. Overview
16.7.2. Revenue Analysis
16.7.3. Product Portfolio
16.7.4. Recent Development
16.8. Bundi International Diagnostics Ltd
16.8.1. Overview
16.8.2. Revenue Analysis
16.8.3. Product Portfolio
16.8.4. Recent Development
16.9. Certest Biotec Sl
16.9.1. Overview
16.9.2. Revenue Analysis
16.9.3. Product Portfolio
16.9.4. Recent Development
16.10. Corisbioconcept Sprl
16.10.1. Overview
16.10.2. Revenue Analysis
16.10.3. Product Portfolio
16.10.4. Recent Development
16.11. F. Hoffman La Roche, Ltd
16.11.1. Overview
16.11.2. Revenue Analysis
16.11.3. Product Portfolio
16.11.4. Recent Development
16.12. Hologic Inc
16.12.1. Overview
16.12.2. Revenue Analysis
16.12.3. Product Portfolio
16.12.4. Recent Development
16.13. Luminex Corporation
16.13.1. Overview
16.13.2. Revenue Analysis
16.13.3. Product Portfolio
16.13.4. Recent Development
16.14. Merck & Co., Inc
16.14.1. Overview
16.14.2. Revenue Analysis
16.14.3. Product Portfolio
16.14.4. Recent Development
16.15. Siemens Healthineers Ag
16.15.1. Overview
16.15.2. Revenue Analysis
16.15.3. Product Portfolio
16.15.4. Recent Development
16.16. Thermo Fisher Scientific
16.16.1. Overview
16.16.2. Revenue Analysis
16.16.3. Product Portfolio
16.16.4. Recent Development
16.17. Perkinelmer, Inc
16.17.1. Overview
16.17.2. Revenue Analysis
16.17.3. Product Portfolio
16.17.4. Recent Development
16.18. Qiagen Nv
16.18.1. Overview
16.18.2. Revenue Analysis
16.18.3. Product Portfolio
16.18.4. Recent Development
17. Swot Analysis
18. Conclusion
19. About Us
20. Related Reports